Quick Notes — Oct. 10, 2023

By PacConAdmin | October 10, 2023 | 0

Guidance updates, Novo Nordisk complaint against semaglutide compounders tossed, and AdvaMed forms new digital tech division, in this edition of Quick Notes.
Source: Drug Industry Daily

Posted in Uncategorized and tagged

Leave a Comment





This site uses Akismet to reduce spam. Learn how your comment data is processed.